Goto
  

Home
President's Messages
Company Profile
Quality Policy
Products
New Product
Toll Manufacturing
Newsletter
Career opportunities
Contact us







 

PRESENTATION:
Oxoferin Sterile Solution is a Brookes speciality, being the only product of its kind available for the treatment of all types of wounds, ranging from minor injuries to the most complicated wounds.

Oxoferin (Topical Solution) contains Tetrachlorodecaoxide, and enjoys the distinction of being the only product that contains oxygen in the solution and stable form.
One more exclusive benefit that makes Oxoferin stand out is its ability to kill all pathogens, though it does not contain any antibiotic.

COMPOSITION:
Each 10ml of Oxoferin Sterile Solution contains:
Chloro-(iv)-oxide-oxygen
Complex (4:1) Hydrate 0.1037mg
Glycerine 200.0mg
In aqua pu'ra

ACTION:
Oxoferin acts by stimulating the immune system of the body, and that is why it is known as Immunomodulator.
When applied topically Oxoferin is absorbed rapidly both by wound surface and border area.
Oxoferin combines with the haem part of haemoglobin, myoglobin and peroxidase, forming a TCDO-haemo complex, this in turn activates the macrophages and accelerates the process of "PHAGOCYTOSIS"
This process of phagocytosis engulfs all the pathogens present on the surface of the wound including the cell debris, thus cleans the wound surface, a prerequisite for Regenerative Phase. Oxoferin also helps in the Regenerative Phase by giving rise to two impulses, namely MITOGENIC and CHEMOTACTIC.
The mitogenic impulse gives rise to two factors, MDGF(Macrophage derived growth factor) and WAF (Wound angiogenesis factor.) The MDGF deposits fibroblasts and synthesizes collagen fibres which fills the gap in the wounds, the WAF helps in the formation of new capillaries which further enhances the healing process. The chemotactic impulse acts on the myocyte(muscle cell) and causes it to contract, thereby reducing the wound surface.
All these three factors are influencing the regenerative phase simultaneously and thus accelerate the wound healing with minimal scarring.


INDICATION:

  • Infected wounds
  • General problem wounds
  • Decubitus ulcers (bed sores)
  • Post operative wounds
  • Post traumatic wounds
  • All degrees of burns
  • Contaminated cuts and injuries
  • Chronic leg ulcers combined with venous Insufficiency
  • Supparative cavities or fistular tracts
  • Tissue preparation for skin grafts and
  • Delayed wound healing and ulcer cases involving impaired arterial circulation, such as in old age & diabetes.

METHOD OF APPLICATION:
Apply directly or cover the wounds with a gauze piece soaked with Oxoferin on the affected area. The quantity of Oxoferin to be applied depends on the size of the wound. Generally 5ml per dressing of 4"x4" twice a day is sufficient. If the area of the wound is big (e.g. in burns), Oxoferin can be applied mixed with normal saline. Oxoferin should be used within 30 days, once the bottle is opened.

CONTRA-INDICATION:
None.

DRUG INTERACTION
Oxoferin being a monotherapeutic agent should not be used with other topical therapeutics.

PACK:
Pack of 10ml plastic bottle.
Pack of 50ml plastic bottle.

INSTRUCTION FOR OPENING THE BOTTLE
To open turn the cap completely over the neck of the bottle.

STORAGE:
Protect from heat and light

NOTE:
Mild itching or burning sensation is an indication that healing process has started. Spontaneous bleeding after application of Oxoferin is a positive sign indicating that capillaries have started to multiply. Excessive application of Oxoferin may cause greenish smear on the wound surface which disappears once the dose is reduced.